Melvin Booth

SAB Healthcare

Melvin Booth serves on Genstar’s Strategic Advisory Board and advises the firm in the area of healthcare.

Mel served on the Boards of Catalent Pharma Solutions, PRA International, eResearch Technologies and MNK Pharmaceuticals. Prior to serving on Boards, Melvin Booth was the Lead Director of Millipore, a life science research company, from 2004 to 2010, member of the Board of Directors of MedImmune, from 1998 to 2005, and Human Genome Sciences from 1995 to 1998.

Prior to joining Millipore, Mel was the Chairman of Prestwick Pharmaceuticals, a provider of specialty pharmaceutical products, until the company was sold in 2008. Before joining Prestwick, he was President of MedImmune, from 1998 to 2003, and President of Humane Genome Sciences, from 1995 to 1998. He held a variety of domestic and international positions with Syntex, from 1981 to 1995, including serving as President of the U.S. pharmaceuticals business. From 1975 to 1981, Mel was Executive President and Vice President of Finance at Dental-Ez Products Corporation.

Mel has been active in U.S. pharmaceutical industry organizations and was a Chairman of the Pharmaceuticals Manufacturers Association of Canada. He has also been active in many educational and philanthropic causes, including the establishment of The Melvin D. and Valorie G. Booth College of Business and Professional Studies at Northwest Missouri State University, located in Maryville, Missouri.

EDUCATION

  • Northwest Missouri State University, Honorary Doctor of Science
  • Northwest Missouri State University, BS, Accounting and Finance
  • Holds a CPA certificate
back to top